In addition, according to the Court, when an advantage granted by a Member State strengthens the position of an undertaking compared with that of other undertakings competing in intra-Union trade, the latter must be regarded as affected by that aid [See, in particular, Case 730/79 Philip Morris v Commission [1980] EU:C:1980:209, para. 11; Case C-53/00 Ferring [2001] EU:C:2001:627, para. 21.]. It is sufficient that the recipient of the advantage competes with other undertakings on markets open to competition. In this regard the Commission observes that pharmaceutical products are widely traded between Member States and that the pharmaceutical market is open to competition.
78 6. ASSESSMENT › 6.1. Existence of aid › Distortion of competition and intra-Union trade, Decision_act (EU) 2015/1300
In forcesince 27 Mar 2015
Judgment of the Court of 17 September 1980. Philip Morris Holland BV v Commission of the European Communities.Decision
17 Sep 1980 · 61979CJ0730
Judgment of the Court (Sixth Chamber) of 22 November 2001. Ferring SA v Agence centrale des organismes de sécurité sociale (ACOSS).Decision
22 Nov 2001 · 62000CJ0053
- case:eu=C-730/79